Allos Therapeutics
Allos Therapeutics's phone number is (303)426-6262
.
Allos Therapeutics is a biopharmaceutical company that develops and commercializes anti-cancer therapeutics. FOLOTYN, the company’s main product is a folate analogue metabolic inhibitor design to accumulate preferentially in cancer cells so as to cause cell death. Allos Therapeutics was founded in 1992 and is headquartered in Westminster, Colorado. As of September 4, 2012, Allos Therapeutics operates as a subsidiary of Spectrum Pharmaceuticals, Inc.
View Top Employees for Allos Therapeutics
HQ | 11080 CirclePoint Road Suite 200 | |
Phone | (303)426-6262 | |
Funding | 0 | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | allos.com | |
Industry | Biotechnology | |
Location | Colorado, United States | |
Employees | 19 | |
linkedin.com/company/allos-therapeutics | ||
HQ | 11080 CirclePoint Road Suite 200 | |
Phone | (303)426-6262 | |
Funding | 0 |
Top Competitors for Allos Therapeutics
Allos Therapeutics Questions
Where are Allos Therapeutics's headquarters?
Allos Therapeutics's headquarters are in 11080 CirclePoint Road Suite 200
What is Allos Therapeutics's phone number?
Allos Therapeutics's phone number is (303)426-6262
What is Allos Therapeutics's official website?
Allos Therapeutics's website is allos.com
How many employees are working in Allos Therapeutics right now?
Allos Therapeutics has
19 employees.
View the Email and Phone Numbers for all 19 working at Allos Therapeutics.
What is Allos Therapeutics's industry?
Allos Therapeutics's industry is
Biotechnology
Who are Allos Therapeutics's top competitors?
Allos Therapeutics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What are Allos Therapeutics's categories?
Allos Therapeutics's categories are Biotechnology, Health Care
What is Allos Therapeutics's location?
Allos Therapeutics's location is
Colorado, United States
What is Allos Therapeutics's funding?
Allos Therapeutics's funding is 0
What is Allos Therapeutics's current status?
Allos Therapeutics's current status is acquired